Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -34.54% is 61% above its 5-year average of -88.60%, near the high end of its 5-year range (-228.67%–0.70%).
As of the fiscal period ended Tuesday, March 31, 2026. 24.02% below its 12-month average of -27.85%.
Reported quarterly return on assets; no daily interpolation. Q4 FY2025 (2026-03-31): -32.69%.
RETURN ON ASSETS (ROA)
-34.54%
RETURN ON ASSETS (ROA) AVG TTM
-27.85%
RETURN ON ASSETS (ROA) AVG 3Y
-120.45%
RETURN ON ASSETS (ROA) AVG 5Y
-88.60%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-24.02%
CURRENT VS 3Y AVG
+71.32%
CURRENT VS 5Y AVG
+61.01%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-30.70%
median of 731 covered companies
CURRENT VS SECTOR MEDIAN
-12.51%
vs the sector median at left
Paranovus Entertainment Technology Ltd.
Market Cap
$3.26M
Return on Assets (ROA)
-34.54%
TTM Avg
-27.85%
3Y Avg
-120.45%
5Y Avg
-88.60%
Market Cap
$3.42M
Return on Assets (ROA)
-206.55%
TTM Avg
-205.58%
3Y Avg
-343.02%
5Y Avg
-343.02%
Market Cap
$3.28M
Return on Assets (ROA)
-111.26%
TTM Avg
-147.41%
3Y Avg
-127.90%
5Y Avg
-106.52%
Market Cap
$3.16M
Return on Assets (ROA)
55.30%
TTM Avg
-3307.76%
3Y Avg
-1681.95%
5Y Avg
-1351.74%
Market Cap
$3.18M
Return on Assets (ROA)
-95.33%
TTM Avg
-115.11%
3Y Avg
-93.94%
5Y Avg
-73.81%
Market Cap
$3.39M
Return on Assets (ROA)
-8.01%
TTM Avg
-37.73%
3Y Avg
-92.58%
5Y Avg
-74.07%
Market Cap
$3.07M
Return on Assets (ROA)
-238.27%
TTM Avg
-211.11%
3Y Avg
-146.32%
5Y Avg
-173.65%
Market Cap
$3.04M
Return on Assets (ROA)
-86.02%
TTM Avg
-152.03%
3Y Avg
-125.45%
5Y Avg
-181.83%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Paranovus Entertainment Technology Ltd. (PAVS) | $3.26M | -34.54% | -27.85% | -120.45% | -88.60% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.42M | -206.55% | -205.58% | -343.02% | -343.02% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.28M | -111.26% | -147.41% | -127.90% | -106.52% |
| MBody AI Ltd. (MBAI)vs › | $3.16M | 55.30% | -3307.76% | -1681.95% | -1351.74% |
| IceCure Medical Ltd (ICCM)vs › | $3.18M | -95.33% | -115.11% | -93.94% | -73.81% |
| Moolec Science S.A. (MLEC)vs › | $3.39M | -8.01% | -37.73% | -92.58% | -74.07% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.07M | -238.27% | -211.11% | -146.32% | -173.65% |
| Revelation Biosciences, Inc. (REVB)vs › | $3.04M | -86.02% | -152.03% | -125.45% | -181.83% |
| Eocene Ltd. (EOCN)vs › | $3.48M | N/A | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | -19.43% | -90.07% | -138.72% | -110.42% |
ROA
-34.5%
ROE
-40.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-03-31 | -34.54% |
| 2025-03-31 | -21.16% |
| 2024-03-31 | -228.67% |
| 2023-03-31 | -197.41% |
| 2022-03-31 | -50.49% |
| 2021-03-31 | 0.70% |
| 2020-03-31 | 14.91% |
| 2019-03-31 | 28.51% |
| 2018-03-31 | 32.75% |
| 2017-03-31 | 34.96% |
